Session 221: Innovative Drug Discovery Technology

Day 1: Afternoon, Thursday, July 25, 2019

Place: Room G, 1st Floor

Chair: Dr. Kiyoshi Nokihara, CEO, HiPep Laboratories, Japan

Chair’s Introduction

Sponsor

Title: Advantages of Applying a New Biophysical Approach to HTS for Lead ID, Lead Validation and Optimization

Dr. Rene Wink, Technical Sales and Application Specialist, NanoTemper Technologies GmbH, Germany

Keynote Speech
Title: Developing and Integrating Novel Drug Discovery Technologies for Screening, Validation and Profiling of Synthetic and Biologics Modalities
Dr. Alexey Rak, Director of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, France

Title: The LEO Science & Tech Hubs: Exploring Cutting-edge Science and Technology in Dermatology

Dr. Tord Labuda, Vice President, R&D Asia-Pacific Hub, LEO Pharma K.K., Japan

Title: Novel Antibody Discovery through DNA Approaches

Dr. Ping Yang, CEO & Chairman, Synbio Technologies LLC, USA

Title: Discovery of Drugs by Using Immobilized-cyclotides on Gel-type Beads and Improved Deconvolution Method

Dr. Kiyoshi Nokihara, CEO, HiPep Laboratories, Japan

Coffee Break

Title: New Paradigms for the Treatment of Infectious Diseases, Role of Drug Discovery

Dr. Domingo Gargallo-Viola, CSO, ABAC Therapeutics, Spain

Title: Ring Distortion of Indole Alkaloids: A New Platform for Drug Discovery

Dr. Robert Huigens, Assistant Professor of Medicinal Chemistry, University of Florida, USA

Title: Insulin Degludec: An Intervention to Reduce Glycemic Variability

Dr. Diana Cristina Henao Carrillo, Professor of Endocrinology, Hospital Universitario San Ignacio – Pontificia Universidad Javeriana, Colombia

Title: Novel Technology of Synthesizing Commercial Available Drugs with Intrinsic Magnetism
Dr. Masanari Umemura, Lecturer, Cardiovascular Research Institute, Yokohama City University, Japan

Session 222: Novel Detection and Analysis Technologies and Instruments in Drug Discovery

Day 2: Morning, Friday, July 26, 2019

Place: Room H, 1st Floor

Co-Chair: Dr. Udo Klotzbach, Fraunhofer Institute for Material and Beam Technology, Germany

Chair’s Introduction

Title: Supramolecular Epigenetics: The Vital Role of Magnesium
Dr. Anthony W. Coleman, Research Director, University of Lyon, France

Title: Chiral HPLC Resolution of a Potentially Serious Global Health Crisis

Dr. Clydewyn M. Anthony, Senior Scientific Liaison, The United States Pharmacopeial Convention, USA

Title: Total Analysis of Absolute NMR Shielding for Biologically Active Chemical Compounds. Theory and Experiments
Dr. Karol Jackowski, Head of NMR Laboratory, University of Warsaw, Poland

Title: Toward Better Understanding of Physical Stability of Amorphous Drugs

Dr. Marian Paluch, Professor, University of Silesia, Poland

Coffee Break

Title: Microphysiological Organ-on-a-chip Systems as Interdisciplinary Platforms for SMEs, Big Pharma, Physicians and Technologists
Dr. Udo Klotzbach, Fraunhofer Institute for Material and Beam Technology, Germany

Title: Microfluidic Models of Pancreatic Tumors to Assess Therapeutic Strategies

Dr. Vincent Senez, Senior MEMS Research Scientist, University of Lille, CNRS/U-Tokyo LIMMS UMI 2820, France

Title: Atorvastatin as a Promising Crystallization Inhibitor of Amorphous Probucol: Dielectric Studies at Ambient and Elevated Pressure

Dr. Justyna Knapik-Kowalczuk, Assistant Professor, Institute of Physics and SMCEBI, University of Silesia, Poland

Title: Retention and Selectivity of Cogent Hydride Based Stationary Phases in Hydrophilic Interaction Liquid Chromatography (HILIC)

Dr. Eman Y. Santali, Assistant Professor, Taif University, Saudi Arabia